B&L Eye Implant Shows Performance As Envisioned For DME In Study
This article was originally published in The Gray Sheet
Executive Summary
Initial study data for Bausch & Lomb's Envision TD implantable drug-delivery technology appear to support the firm's inclusion of the combination device as a key component of its growth strategy